Steve Mizell is executive vice president and chief human resources officer at Merck. He has responsibility for all aspects of human resources including talent acquisition and development, employee wellness, and diversity and inclusion.
Under Steve’s leadership, Merck has been recognized as a great place to work by Fortune, Fast Company, Working Mother, U.S. Veterans and People magazines. Steve joined Merck in 2018 from Monsanto, where he served as executive vice president, human resources, and was responsible for creating an industry-leading workplace for more than 20,000 employees around the world. Previously, he served as senior vice president and chief corporate resources officer for AdvancePCS, a pharmacy benefit management company, and has also held key human resources management roles at companies across the energy, defense, beverage and technology sectors.
Steve is currently a resident of New Jersey and Missouri. He serves on the boards of Allegion Plc. and Group 1 Automotive, and is a former board member of Oshkosh Corporation, where he chaired the human resources committee. Recognized as one of St. Louis’ most influential diverse business leaders, he is a longtime supporter of the National Kidney Foundation, Habitat for Humanity, and Youth in Need.
Steve holds a B.S. from Georgia Institute of Technology and an M.S. in management from Carnegie Mellon University. He is also certified by the National Association of Corporate Directors (NACD).
What is Steven Mizell's net worth?
The estimated net worth of Steven Mizell is at least $806.80 as of July 29th, 2025. Mr. Mizell owns 8 shares of Merck & Co., Inc. stock worth more than $807 as of December 5th. This net worth evaluation does not reflect any other assets that Mr. Mizell may own. Learn More about Steven Mizell's net worth.
How do I contact Steven Mizell?
Has Steven Mizell been buying or selling shares of Merck & Co., Inc.?
Steven Mizell has not been actively trading shares of Merck & Co., Inc. over the course of the past ninety days. Most recently, Steven Mizell sold 50,694 shares of the business's stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $126.65, for a transaction totalling $6,420,395.10. Following the completion of the sale, the executive vice president now directly owns 23,619 shares of the company's stock, valued at $2,991,346.35. Learn More on Steven Mizell's trading history.
Who are Merck & Co., Inc.'s active insiders?
Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Michael Holston (EVP), Rita Karachun (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), Wendell Weeks (Director), and David Williams (Executive vice president, chief information & digital officer). Learn More on Merck & Co., Inc.'s active insiders.
Are insiders buying or selling shares of Merck & Co., Inc.?
During the last year, Merck & Co., Inc. insiders bought shares 1 times. They purchased a total of 2,833 shares worth more than $250,012.25. During the last year, insiders at the sold shares 3 times. They sold a total of 15,237 shares worth more than $1,282,329.74. The most recent insider tranaction occured on November, 3rd when EVP David Michael Williams sold 8,614 shares worth more than $720,044.26. Insiders at Merck & Co., Inc. own 0.1% of the company.
Learn More about insider trades at Merck & Co., Inc.. Information on this page was last updated on 11/3/2025.
